2 completed, 2 terminated, 1 unknown. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 2, Terminated 2, Unknown 1 |
Follow Hypogonadotropic Hypogonadism: new trials by email Literature Review of Hypogonadotropic Hypogonadism trials Research Report on Hypogonadotropic Hypogonadism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial Letrozole 2.5mg, hCG, Placebo - Hypogonadism, Hypogonadism, Male | Phase 4 | Terminated | Copenhagen University Hospital, Rigshospitalet | 8 | 2021-11-24 | 2024-02-15 |
| A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism Aveed Injectable Product, Fortesta, Testim - Hypogonadism, Hypogonadism, Male | Phase 4 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 673 | 2020-06-30 | 2025-03-14 |
| Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic Hypogonadism Human Menopausal Gonadotropin, Human Chorionic Gonadotropin - Kallmann Syndrome, Hypogonadotropic Hypogonadism | Phase 4 | Unknown | Beijing Children's Hospital | 40 | 2016-08-01 | 2016-08-26 |
| Sequential Therapy for Hypogonadotropic Hypogonadism Traditional intervention for HH using HCG and FSH, Sequential intervention for HH using HCG and FSH, Sequential intervention for HH using HCG and FSH plus zinc - Hypogonadotropic Hypogonadism, Kallmann Syndrome | Phase 4 | Completed | Shanghai Jiao Tong University School of Medicine | 100 | 2009-09-01 | 2014-02-11 |
| Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L]) Luveris® 75 IU, Luveris® 25 IU, Placebo - Hypogonadotropic Hypogonadism | Phase 4 | Terminated | EMD Serono | 11 | 2006-03-01 | 2013-08-07 |
Hypogonadism (5) · Eunuchism (2) · Kallmann Syndrome (2)
Endocrine System Diseases (5) · Gonadal Disorders (5) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Disorder of Sex Development, 46,XY (2) · Disorders of Sex Development (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genetic Diseases, Inborn (2) · Male Urogenital Diseases (2) · Urogenital Abnormalities (2) · Urogenital Diseases (2)
Chorionic Gonadotropin (2) · Glycoprotein Hormones, alpha Subunit (1) · Letrozole (1) · Luteinizing Hormone, beta Subunit (1) · Menotropins (1) · Testosterone (1) · Testosterone Propionate (1) · Zinc (1) · follitropin alfa (1) · testosterone undecanoate (1)
Beijing Children's Hospital (1) · Copenhagen University Hospital, Rigshospitalet (1) · EMD Serono (1) · Endo USA Inc., a Keenova Therapeutics Company (1) · Shanghai Jiao Tong University School of Medicine (1)
China (2) · United States (2) · Denmark (1)
Caroline Michaela Kistorp, professor, MD (1) · Chunxiu Gong, doctor (1) · David Hernandez (1) · Xiao-Ying Li, MD,PhD (1)